A rare and unusual case of isolated cerebellar metastasis from a non-muscle invasive transitional cell carcinoma of bladder by D'Souza, Nigel et al.
A rare and unusual case of isolated
cerebellar metastasis from a
non-muscle invasive transitional
cell carcinoma of bladder
Nigel D’Souza ￿ Muhammad J Khan ￿ Simon Robinson ￿
Hanif Motiwala
Urology Department, Wexham Park Hospital, Slough, UK
Correspondence to: MJ Khan. E-mail: dmjkhan@yahoo.com
Cerebellar metastases from bladder cancer are
rare, but with timely diagnosis may be treated suc-
cessfully by surgical and adjuvant therapies.
Introduction
Cerebellar metastases from superﬁcial bladder
cancer are extremely rare. Bladder cancer is the
second most common cancer of the urinary tract.
It is the fourth most common cancer in men and
eight most common in women in Europe where
its incidence is estimated at 104,000 in 2006.
Seventy percent
1 of bladder cancer is conﬁned to
the mucosa (Ta, CIS-T1), but 30% is invasive. The
most common solid organs with metastatic
spread are lung (24–36%) and liver (21–35%).
Brain metastases are rare, with previous estimates
at 0.3–8%.
2
We present the case of a successfully treated
solitary cerebellar metastasis that presented 11
months following resection of organ-conﬁned
transition cell carcinoma.
Case report
A 69-year-old woman was seen bya GP with pain-
less visible haematuria and enterococcus urinary
tract infection. Her only other co-morbidity was
of epilepsy well-controlled with medication. Treat-
ment with antibiotics cleared up the haematuria,
and she was referred to the outpatient urology
haematuria clinic in January 2008.
She had a ﬂexible cystoscopy in February 2008,
which showed a large mass on the right lateral
wall. A computed tomography (CT) scan
showed at least a 2 cm mass on the right lateral
wall. She underwent a transurethral resection of
her bladder tumour in March 2008. Staging CT
and ultrasound scan showed no evidence of
lymph node or metastatic spread (Figure 1).
Histology from the transurethral resection of
her bladder tumour revealed a G3pT1 tumour
with probable lymphatic invasion, but no muscle
involvement or evidence of carcinoma in situ.
The patient then underwent six cycles of BCG
instillation. Follow-up biopsies taken in April
and August 2008 showed no malignancy.
In January 2009, she developed new onset slur-
ring of speech, left-sided facial drooping, left eye
visual disturbance and ataxia. She was diagnosed
with a Tegretol overdose by her GP. Following pro-
gression of her symptoms over three weeks, she
was urgently referred to a neurologist. Her signs
now also included nausea, confusion and head-
aches, and she was admitted to hospital for an
urgent CT scan of her head. This revealed a
4.8 cm mass in the right cerebellum (Figure 2).
She was immediately transferred to the local
neurosurgical unit, and underwent de-bulking of
posterior fossa metastases. Histology of the
biopsy showed ‘cerebellar tissue inﬁltrated by an
epithelial tumour composed of papillae of moder-
ately atypical cells with weakly eosinophilic cyto-
plasm. Surrounding tissue shows reactive gliosis,
chronic inﬂammation and granulation tissue’,
with a ﬁnal diagnosis of ‘metastatic transitional
cell carcinoma consistent with bladder primary’.
Subsequent immunocytochemistry showed ‘the
immunoreaction for 34BE12 is positive in neoplas-
tic cells conﬁrming the diagnosis of metastastic
transitional cell carcinoma’.
She subsequently had full brain radiotherapy,
30Gy in 10 fractions. Herone-month postoperative
MRI showed only postoperative changes, and
whole-body CT showed no other metastasis.
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CASE REPORT
1Flexible cystoscopy done in October of that year
did not reveal any recurrence. She remains well,
21 months post neurosurgery with no evidence
of local recurrence or metastatic disease.
Discussion
Transitional cell carcinoma is the most common
(>90%) primary bladder cancer. Risk factors for
bladder cancer are smoking, male gender, increas-
ing age, exposure to industrial and environmental
carcinogens, chronic inﬂammation of bladder
(bladder stones, long-term catheters and ova of scis-
tosoma haematobium), drugs (phenacitin and
cyclophosmamide) andpelvicradiation. No heredi-
tary genetic cause for bladder cancer has been
identiﬁed but some somatic genetic abnormalities
have been reported. These are loss of chromosomes
9p, 9q, 11p 13q and 17q. Furthermore, activation of
o n c o g e n e s( p 2 1 r a s ,c - m y c ,c - j u n ,e r b B - 2 ) ,i n a c t i -
vation of tumour suppressor genes (p53, retinoblas-
toma, p16 cyclin-dependent kinase inhibitor) and
increased expressionofangiogenic factors (vascular
endothelial growth factor) are identiﬁed in transi-
tional cell carcinoma.
Brain metastases from transition cell carcinoma
of the bladder remains rare. A suggested mechan-
ism for metastasis to the cerebellum is through ret-
rograde dissemination via Batson’s plexus to the
vertebral venous system, to reach the intracranial
venous sinuses. The time period for detection of
metastases has been found in other studies to be
between 7 to 40 months post-surgical treatment
of primary transition cell carcinoma. Cerebellar
metastases are more rare even than cerebral metas-
tases. The ﬁrst case of an isolated cerebellar metas-
tasis was reported back in 1930.
3 There have been
six cases reported in the literature
4–7of cerebellar
metastases, nearly always with a high grade, high
stage primary bladder cancer. This is only the
second case
7 we have found reported of T1
bladder transition cell carcinoma, treated with
surgical resection, that later developed a solitary
cerebellar metastasis with no systemic relapse.
Conclusion
Brain metastasis from a non-muscle invasive
bladder tumour is rare, but it should be con-
sidered as a differential diagnosis in a patient pre-
senting with new focal neurological signs and
known history of bladder cancer.
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